{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/107181277"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Consideration can be given to discontinuing secondary CMV prophylaxis in adolescents with sustained (e.g., for ???6 months) increase in CD4+ T-cell counts to >100???150/mm3 in response to potent antiretroviral therapy.317 This decision should be made in consultation with an ophthalmologist and factors such as the magnitude and duration of CD4+ T-cell increase, anatomic location of the retinal lesi" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "drugs.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/136748814"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/107181277"] } } }
